Related Experiment Videos
Intravenous access: related problems in oncology.
1Centre Antoine-Lacassagne, 33 Avenue de Valombrose, 06189 Nice Cedex 2, France.
International Journal of Antimicrobial Agents
|October 29, 2000
Summary
Diagnosing and treating catheter-related bloodstream infections (CRBI) in oncology patients is evolving. Paired blood cultures aid diagnosis without device removal, and new prevention strategies are emerging.
Area of Science:
- Oncology
- Infectious Diseases
- Medical Devices
Background:
- Hickman central venous catheters (CVCs) and totally implanted venous ports are crucial in oncology.
- Catheter-related bloodstream infections (CRBI) pose a significant risk to patients.
Purpose of the Study:
- To review recent advancements in diagnosing and managing CRBI in oncology patients.
- To present a decision-tree for CRBI management without device removal.
- To explore future trends in CRBI prevention and treatment.
Main Methods:
- Literature review of recent developments concerning CVCs and venous ports.
- Analysis of international data to create a CRBI management decision-tree.
- Review of emerging techniques for CRBI prevention and treatment.
Main Results:
- Paired quantitative blood cultures are identified as a reliable method for diagnosing CRBI without device removal.
- A decision-tree/flow-chart for managing CRBI has been developed by international experts.
- New preventive strategies include antimicrobial-impregnated catheters and antiseptic hubs.
Conclusions:
- CRBI diagnosis can be achieved non-invasively, facilitating timely treatment.
- Device removal may not always be necessary for CRBI cure.
- Innovative prevention and treatment methods, including antibiotic lock techniques, are advancing CRBI management.